• This record comes from PubMed

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

. 2017 Feb ; 24 (2) : 292-301. [epub] 20161122

Language English Country Great Britain, England Media print-electronic

Document type Journal Article

BACKGROUND AND PURPOSE: While impaired cognitive performance is common in multiple sclerosis (MS), it has been largely underdiagnosed. Here a magnetic resonance imaging (MRI) screening algorithm is proposed to identify patients at highest risk of cognitive impairment. The objective was to examine whether assessment of lesion burden together with whole brain atrophy on MRI improves our ability to identify cognitively impaired MS patients. METHODS: Of the 1253 patients enrolled in the study, 1052 patients with all cognitive, volumetric MRI and clinical data available were included in the analysis. Brain MRI and neuropsychological assessment with the Brief International Cognitive Assessment for Multiple Sclerosis were performed. Multivariable logistic regression and individual prediction analysis were used to investigate the associations between MRI markers and cognitive impairment. The results of the primary analysis were validated at two subsequent time points (months 12 and 24). RESULTS: The prevalence of cognitive impairment was greater in patients with low brain parenchymal fraction (BPF) (<0.85) and high T2 lesion volume (T2-LV) (>3.5 ml) than in patients with high BPF (>0.85) and low T2-LV (<3.5 ml), with an odds ratio (OR) of 6.5 (95% CI 4.4-9.5). Low BPF together with high T2-LV identified in 270 (25.7%) patients predicted cognitive impairment with 83% specificity, 82% negative predictive value, 51% sensitivity and 75% overall accuracy. The risk of confirmed cognitive decline over the follow-up was greater in patients with high T2-LV (OR 2.1; 95% CI 1.1-3.8) and low BPF (OR 2.6; 95% CI 1.4-4.7). CONCLUSIONS: The integrated MRI assessment of lesion burden and brain atrophy may improve the stratification of MS patients who may benefit from cognitive assessment.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis

. 2024 Feb ; 124 (1) : 109-118. [epub] 20230808

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis

. 2023 ; 16 () : 17562864231180719. [epub] 20230625

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

. 2021 Mar 07 ; 11 (3) : . [epub] 20210307

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

. 2020 ; 13 () : 1756286420975223. [epub] 20201207

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis

. 2019 ; 10 () : 820. [epub] 20190806

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

. 2018 ; 17 () : 444-451. [epub] 20171105

Cognitive clinico-radiological paradox in early stages of multiple sclerosis

. 2018 Jan ; 5 (1) : 81-91. [epub] 20171215

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...